Karolinska Development AB ser. B Cash Flow Conversion Efficiency

Latest as of March 2026: -0.004x

Karolinska Development AB ser. B cash flow conversion efficiency. Based on the latest financial reports, Karolinska Development AB ser. B (KDEV) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.18 Million ≈ $-449.51K USD) by net assets (Skr1.10 Billion ≈ $118.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Karolinska Development AB ser. B (2008–2025)

Cash flow conversion efficiency of Karolinska Development AB ser. B from 2008 to 2025. This chart illustrates how Karolinska Development AB ser. B's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Karolinska Development AB ser. B stock price for real-time trading data and today's change.

Karolinska Development AB ser. B Cash Flow Conversion Ratio Explained

Karolinska Development AB ser. B cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Karolinska Development AB ser. B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Karolinska Development AB ser. B ranked by their cash flow conversion efficiency. Also see market value of Karolinska Development AB ser. B for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Taya Inv-L TA:TAYA	0.002x
Klondike Gold Corp V:KG	-0.008x
Klimasan Klima Sanayi ve Ticaret AS IS:KLMSN	0.149x
DarioHealth Corp NASDAQ:DRIO	-0.100x
Tamul Multimedia Co. Ltd KQ:093640	-0.041x
Artea SA PA:ARTE	-0.078x
WIZIT Co. Ltd KQ:036090	0.055x
Bubang Co. Ltd KQ:014470	0.043x

Annual Cash Flow Conversion Efficiency for Karolinska Development AB ser. B (2008–2025)

The table below shows the annual cash flow conversion efficiency of Karolinska Development AB ser. B from 2008 to 2025. Review Karolinska Development AB ser. B free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr1.04 Billion ≈ $112.44 Million	Skr-26.06 Million ≈ $-2.80 Million	-0.025x	-11.01%
2024-12-31	Skr1.24 Billion ≈ $133.31 Million	Skr-27.83 Million ≈ $-2.99 Million	-0.022x	-11.95%
2023-12-31	Skr1.25 Billion ≈ $134.18 Million	Skr-25.02 Million ≈ $-2.69 Million	-0.020x	+23.42%
2022-12-31	Skr1.24 Billion ≈ $133.60 Million	Skr-32.53 Million ≈ $-3.50 Million	-0.026x	-252.38%
2021-12-31	Skr971.09 Million ≈ $104.50 Million	Skr16.70 Million ≈ $1.80 Million	0.017x	+141.46%
2020-12-31	Skr800.27 Million ≈ $86.12 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.041x	-464.27%
2019-12-31	Skr1.01 Billion ≈ $108.45 Million	Skr-7.41 Million ≈ $-797.33K	-0.007x	-116.54%
2018-12-31	Skr296.01 Million ≈ $31.86 Million	Skr13.15 Million ≈ $1.42 Million	0.044x	+4.76%
2017-12-31	Skr267.12 Million ≈ $28.75 Million	Skr11.33 Million ≈ $1.22 Million	0.042x	+114.06%
2016-12-31	Skr29.82 Million ≈ $3.21 Million	Skr-8.99 Million ≈ $-967.90K	-0.302x	+76.99%
2015-12-31	Skr247.88 Million ≈ $26.68 Million	Skr-325.02 Million ≈ $-34.98 Million	-1.311x	-1890.69%
2014-12-31	Skr1.65 Billion ≈ $177.09 Million	Skr-108.39 Million ≈ $-11.66 Million	-0.066x	-50.19%
2013-12-31	Skr1.87 Billion ≈ $201.28 Million	Skr-82.03 Million ≈ $-8.83 Million	-0.044x	+41.84%
2012-12-31	Skr2.02 Billion ≈ $217.84 Million	Skr-152.65 Million ≈ $-16.43 Million	-0.075x	-22.86%
2011-12-31	Skr2.17 Billion ≈ $233.95 Million	Skr-133.44 Million ≈ $-14.36 Million	-0.061x	-8.30%
2010-12-31	Skr1.72 Billion ≈ $184.80 Million	Skr-97.32 Million ≈ $-10.47 Million	-0.057x	-231.51%
2009-12-31	Skr2.00 Billion ≈ $215.05 Million	Skr-34.16 Million ≈ $-3.68 Million	-0.017x	-56.75%
2008-12-31	Skr1.65 Billion ≈ $177.66 Million	Skr-18.00 Million ≈ $-1.94 Million	-0.011x	--

About Karolinska Development AB ser. B

ST:KDEV Sweden Biotechnology

Market Cap

$29.36 Million

Skr272.85 Million SEK

Market Cap Rank

#23646 Global

#446 in Sweden

Share Price

Skr0.29

Change (1 day)

+0.00%

52-Week Range

Skr0.25 - Skr0.86

All Time High

Skr10.82